RDY · Dr Reddys Laboratories Ltd

$11.76 +0.03 (+0.26%) At close · Jul 29

Market Cap

$9.80B

833.00M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2024-07-29	Israeli Erez	Officer, Director	65,500	$5,390,000	2024-07-29	MERRILL LYNCH
2023-10-27	Israeli Erez	Officer	5,000	$327,250	2023-10-30	Merrill Lynch, Pierce, Fenner & Smith Inc.
2023-07-27	Israeli Erez	Officer, Director	197,165	$13,200,000	2023-07-29	MERRILL LYNCH

Showing 1–3 of 3 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 80 filings 59 filers Visit website Investor relations